Related Experiment Videos
Nimodipine-induced acute hypoxemia: case report.
J W Devlin1, W M Coplin, K R Murry
1Department of Pharmacy, Wayne State University, Detroit Receiving Hospital, Michigan 48201, USA. jdevlin@dmc.org
Neurosurgery
|November 4, 2000
Summary
Nimodipine, used for subarachnoid hemorrhage, can cause severe hypoxemia in patients with adult respiratory distress syndrome. This case highlights the need for careful oxygenation monitoring during nimodipine treatment.
Area of Science:
- Neurology
- Critical Care Medicine
- Pharmacology
Background:
- Nimodipine is a calcium channel blocker frequently used to improve neurological outcomes following subarachnoid hemorrhage.
- While known for cerebral specificity, nimodipine can cause systemic adverse effects, including hypotension.
- This report details a novel, severe adverse reaction to nimodipine.
Observation:
- A patient with traumatic subarachnoid hemorrhage experienced two episodes of life-threatening hypoxemia.
- These episodes were temporally linked to single doses of nimodipine administration.
- No other causes could explain the severe drops in oxygen levels.
Findings:
- Acute hypoxemia occurred with partial pressures of oxygen as low as 32.9 mm Hg.
- Supportive oxygen therapy (100% inspired oxygen and positive end-expiratory pressure) resolved hypoxemia within 40 minutes.
- Nimodipine discontinuation preceded resolution of hypoxemia.
Implications:
- Nimodipine may exacerbate ventilation/perfusion mismatch in patients with adult respiratory distress syndrome via pulmonary artery vasodilation.
- The drug might interfere with hypoxic pulmonary vasoconstriction, impairing oxygenation.
- Close monitoring of oxygenation is crucial when initiating nimodipine therapy, especially in critically ill patients.